Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan
· Delayed Price · Currency is TWD 177.00
-0.50 (-0.28%)
Aug 15, 2025, 1:30 PM CST
Alar Pharmaceuticals Revenue
Alar Pharmaceuticals had revenue of 1.25M TWD in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 7.07M, down -98.49% year-over-year. In the year 2024, Alar Pharmaceuticals had annual revenue of 5.82M, down -98.76%.
Revenue (ttm)
7.07M
Revenue Growth
-98.49%
P/S Ratio
1,672.36
Revenue / Employee
261.85K
Employees
27
Market Cap
11.82B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 44.83M |
| PharmaEssentia | 12.63B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 112.57M |
| Lumosa Therapeutics | 37.25M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |